echoloc

Regeneron Tech Stack

Biopharmaceutical R&D and commercialization with global manufacturing and clinical operations

Biotechnology Tarrytown, New York 10,001+ employees Public Company

Regeneron operates a large-scale biopharmaceutical development and manufacturing engine built on life sciences software (Epic, Veeva, LIMS, JMP, SAS) paired with analytics stacks (Python, R, SQL, scikit-learn, Tableau, Power BI). The hiring profile is clinical and research-heavy (research 118 roles, healthcare 76, senior/director bias), while active projects span late-stage clinical trials (obesity, respiratory, multiple myeloma), market access strategy, and Oracle ERP migration — indicating a shift toward financial and procurement automation as the company scales commercialization. Pain-point clustering around GMP/GXP compliance, data integrity, and reimbursement access signals friction in regulated drug development and market entry.

Tech Stack 200 technologies

Core StackWorkday AWS ServiceNow Epic Systems Python C++ pandas NumPy scikit-learn Power BI Tableau Power Automate MATLAB SAS Oracle R HPLC SQL Polars LIMS Microsoft Office JMP Veeva Excel SAS JMP Word Adobe Acrobat PowerPoint QlikView Microsoft Project+170 more
AdoptingOracle Financials Cloud Oracle Fusion Cloud Financials ITIL SharePoint
ReplacingOracle EBS

What Regeneron Is Building

Challenges

  • Ensuring cgmp compliance
  • Compliance with gxps
  • Process gaps
  • Data integrity
  • Cost savings
  • Budget management
  • Reimbursement and access challenges
  • Meeting p&l targets
  • Complex markets across diverse customer segments
  • Cash flow improvement

Active Projects

  • Crm data analysis
  • Market access strategy development
  • Oracle fusion cloud procurement implementation
  • Global raw material / chemicals category strategy implementation
  • Launch of multiple myeloma product
  • Obesity clinical development program
  • Territory account plan development
  • User acceptance testing
  • Process scale-up
  • Post-approval interventional and non-interventional respiratory clinical trials

Hiring Activity

Accelerating700 roles · 360 in 30d

Department

Sales
127
Research
118
Healthcare
76
Engineering
66
Ops
62
Data
50
Manufacturing
32
Finance
26

Seniority

Senior
251
Director
146
Mid
105
Manager
75
Junior
53
Principal
26
Intern
7
Staff
7

Notable leadership hires: Clinical Study Lead, Medical Director, Imaging Scientific Director, Director Insights, Medical Affairs Lead

Company intelligence

Find more companies like Regeneron by tech stack, pain points and active projects

Get started free

About Regeneron

Regeneron is a publicly traded biopharmaceutical company headquartered in Tarrytown, New York, with 10,000+ employees across the United States, United Kingdom, Japan, Ireland, Netherlands, Germany, and other countries. The company invents, develops, and commercializes medicines for serious diseases, operating integrated R&D, clinical, manufacturing, and commercial functions. Core operational systems include Epic for clinical/healthcare workflows, Veeva for life sciences data management, LIMS for lab operations, and analytical tools (JMP, SAS, Python, R) embedded in research and manufacturing processes. Active infrastructure modernization includes migration from Oracle EBS to Oracle Fusion Cloud Financials and adoption of ITIL frameworks.

HeadquartersTarrytown, New York
Company Size10,001+ employees
Hiring MarketsUnited Kingdom, United States, Japan, Ireland, Netherlands, Germany, Benin, Canada

Frequently Asked Questions

What is Regeneron's tech stack?

Life sciences (Epic, Veeva, LIMS, JMP, SAS), analytics (Python, R, SQL, scikit-learn, Tableau, Power BI), ERP (Workday, ServiceNow, Oracle), and laboratory instruments (HPLC). Currently migrating to Oracle Fusion Cloud Financials from Oracle EBS.

What products is Regeneron developing?

Active pipeline includes multiple myeloma and obesity medicines in clinical development, plus respiratory clinical trials (post-approval interventional and non-interventional). Territory and market access strategy development is underway across multiple therapeutic areas.

Similar Companies in Biotechnology

Other companies in the same industry, closest in size